About CartaBio
CartaBio is headquartered in Wilmington, United States, with operations centered in the biotech industry. An AI-based platform is developed to provide live cell imaging solutions. Focus is placed on AI-integrated technologies, including scission accelerated fluorophore exchange and the multimodal CellBERT model. These tools are applied to support biotech applications, enabling advanced cellular analysis and research workflows.
- Headquarter Wilmington, United States
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Dann Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CartaBio
Investors in CartaBio
CartaBio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Dann Capital, Coho and Industry Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CartaBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CartaBio
Investment portfolio details for CartaBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CartaBio
Detailed financials for CartaBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cartabio Comparisons
Peer comparison for CartaBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CartaBio
Detailed competitors of CartaBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cartabio
Complete news archive for CartaBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CartaBio
CartaBio is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Robert Yang is the current CEO of CartaBio.
CartaBio is headquartered in Wilmington, United States, with operations centered in the biotech industry. An AI-based platform is developed to provide live cell imaging solutions. Focus is placed on AI-integrated technologies, including scission accelerated fluorophore exchange and the multimodal CellBERT model. These tools are applied to support biotech applications, enabling advanced cellular analysis and research workflows.
CartaBio has 3 investors. Key investors include Dann Capital, Coho, and Industry Capital.